These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 27890789

  • 21. Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
    Veloso Alves Pereira I, Buchmann B, Sandmann L, Sprinzl K, Schlaphoff V, Döhner K, Vondran F, Sarrazin C, Manns MP, Pinto Marques Souza de Oliveira C, Sodeik B, Ciesek S, von Hahn T.
    PLoS One; 2015; 10(2):e0117152. PubMed ID: 25646622
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
    Saso W, Tsukuda S, Ohashi H, Fukano K, Morishita R, Matsunaga S, Ohki M, Ryo A, Park SY, Suzuki R, Aizaki H, Muramatsu M, Sureau C, Wakita T, Matano T, Watashi K.
    Biochem Biophys Res Commun; 2018 Jun 22; 501(2):374-379. PubMed ID: 29730285
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors.
    Kirstgen M, Lowjaga KAAT, Müller SF, Goldmann N, Lehmann F, Glebe D, Baringhaus KH, Geyer J.
    Viruses; 2021 Apr 12; 13(4):. PubMed ID: 33921515
    [Abstract] [Full Text] [Related]

  • 25. Interactions of Na+/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy.
    Zakrzewicz D, Geyer J.
    Biol Chem; 2023 Jun 27; 404(7):673-690. PubMed ID: 37103224
    [Abstract] [Full Text] [Related]

  • 26. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T, Sugimoto-Ishige A, Nishitsuji H, Futamura Y, Harada M, Kimura-Someya T, Matsumoto T, Honma T, Tanaka M, Yaguchi M, Isono K, Koseki H, Osada H, Miki D, Saito T, Tanaka T, Fukami T, Goto T, Shirouzu M, Shimotohno K, Chayama K.
    J Virol; 2022 Mar 09; 96(5):e0168621. PubMed ID: 34985994
    [Abstract] [Full Text] [Related]

  • 27. IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection.
    Palatini M, Müller SF, Kirstgen M, Leiting S, Lehmann F, Soppa L, Goldmann N, Müller C, Lowjaga KAAT, Alber J, Ciarimboli G, Ziebuhr J, Glebe D, Geyer J.
    Viruses; 2022 Mar 30; 14(4):. PubMed ID: 35458456
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F, Fardel O, Gripon P.
    Virology; 2015 Jul 30; 481():34-42. PubMed ID: 25765005
    [Abstract] [Full Text] [Related]

  • 29. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L, Sui J, Luo G.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30232184
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.
    Okuyama-Dobashi K, Kasai H, Tanaka T, Yamashita A, Yasumoto J, Chen W, Okamoto T, Maekawa S, Watashi K, Wakita T, Ryo A, Suzuki T, Matsuura Y, Enomoto N, Moriishi K.
    Sci Rep; 2015 Nov 23; 5():17047. PubMed ID: 26592202
    [Abstract] [Full Text] [Related]

  • 32. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP.
    Huang H, Huang HC, Chiou WC, Lin LC, Chen JC, Liu HK, Lai YH, Huang C.
    Antiviral Res; 2021 Nov 23; 195():105184. PubMed ID: 34627935
    [Abstract] [Full Text] [Related]

  • 33. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y, Gu W, Dansako H, Nishitsuji H, Satoh S, Shimotohno K, Kato N.
    Biochem Biophys Res Commun; 2019 Jul 12; 515(1):156-162. PubMed ID: 31133379
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
    Wang XJ, Hu W, Zhang TY, Mao YY, Liu NN, Wang SQ.
    Antiviral Res; 2015 Aug 12; 120():140-6. PubMed ID: 26086883
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.